Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 30, 2018

Primary Completion Date

April 18, 2019

Study Completion Date

August 30, 2019

Conditions
Kidney DiseasesCardiovascular Diseases
Interventions
DIETARY_SUPPLEMENT

Commercially available Diindolylmethane

Commercially available Diindolylmethane is a compound derived from cruciferous vegetables (e.g. broccoli)

OTHER

Placebo

A matching placebo capsule will be compounded by the UPMC Investigational Drug Service

Trial Locations (1)

15261

University of Pittsburgh, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT03152097 - Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study | Biotech Hunter | Biotech Hunter